More NewsRead More
Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment
March 06, 2015
Veracyte Announces Publication of Data Demonstrating Analytical and Clinical Validity of Its Afirma® BRAF Malignancy Classifier
February 05, 2015
Veracyte, Inc. Names Dr. Robert S. Epstein to Its Board of Directors
January 12, 2015
Veracyte Announces Positive Coverage Policy for Afirma® Gene Expression Classifier from Blue Shield of California
December 02, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here